Spontaneous Retroperitoneal Hematoma: A Deadly Complication for Patients Awaiting Liver Transplant. Cureus 2022 Dec;14(12):e32522
Date
01/20/2023Pubmed ID
36654646Pubmed Central ID
PMC9838682DOI
10.7759/cureus.32522Abstract
BACKGROUND: Patients with end-stage liver disease (ESLD) are at increased risk for hemorrhage and spontaneous retroperitoneal hematoma (sRPH) and also carry a high mortality rate. We sought to review the natural history of sRPH in patients with ESLD at a single center.
METHODS: All patients admitted to a single transplantation intensive care unit (TICU) at Froedtert and the Medical College of Wisconsin Transplant Center between June 2016 and August 2018 were retrospectively reviewed. Six ESLD patients with sRPH were studied. Clinical outcome measures were liver disease severity, sRPH treatment, and patient survival.
RESULTS: Six patients were included, four male and two female patients, with a median age of 56.5 years (range 30-67 years). All had alcohol-induced liver cirrhosis. The median Model for End-Stage Liver Disease (MELD) score at the time of sRPH diagnosis was 40 (range 30-43). The most commonly identified source of bleeding was from lumbar arteries. One patient had recurrent bleeding after embolization and underwent repeat embolization. Five patients died. The median time to death from the diagnosis of sRPH was 7.2 days (range 2-12 days). The patient who survived following embolization had the lowest MELD score.
CONCLUSION: Critically ill cirrhotic patients with sRPH have a significant mortality rate. Embolization is successful, albeit seldom. This is the largest retrospective series of sRPH in cirrhotic patients in the literature.
Author List
Rawashdeh B, Kim J, Hong JAuthors
Joohyun Kim MD, PhD Associate Professor in the Surgery department at Medical College of WisconsinBadi Rawashdeh MBBS Instructor in the Surgery department at Medical College of Wisconsin
